Correlation Study on Expression of PD-1 and PD-L1 in Non-small Cell Lung Cancer and Epidermal Growth Factor Receptor Mutations

Background and objective The treatment mode of lung cancer is epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) as a first-line treatment for patients with EGFR mutant in non-small cell lung cancer (NSCLC). At the same time programmed death receptor 1 (PD-1) and its programmed...

Full description

Bibliographic Details

Published in:	Chinese Journal of Lung Cancer
Main Authors:	Ling JIANG, Zhiyi LIN, Na LI, Jinfang JIANG, Cengceng LU, Shenghang DU, Jun ZHANG, Yuanyuan WANG, Jun CHEN, Ping GONG
Format:	Article
Language:	Chinese
Published:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2021-09-01
Subjects:	lung neoplasms programmed death receptor 1 programmed death receptor ligand 1 epidermal growth factor receptor immunohistochemical
Online Access:	http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.31